Differential diagnosis of cancer and other conditions based on expression of p63
View Patent ↗This invention relates to methods of distinguishing among various types of differentiated and undifferentiated epithelial carcinomas, and non-epithelial carcinomas, by detecting the presence of p63 nucleic acid or protein expression. The invention also provides methods for detecting p63 nucleic acids and proteins, as well as methods for diagnosing and treating certain tumors based on whether the tumors express p63.
1. A method for distinguishing a differentiated squamous cell lung cancer carcinoma from an undifferentiated lung cancer carcinoma, which method comprises detecting p63 expression in cells from a lung carcinoma, wherein consistent p63 expression indicates that the lung carcinoma is a squamous cell lung carcinoma and the absence of p63 expression indicates that the lung carcinoma is an undifferentiated lung carcinoma.
2. The method according to claim 1 wherein detecting p63 expression comprises detecting expression of p63 protein.
3. The method according to claim 2 wherein detecting p63 protein expression comprises detecting the p63 protein with an immunoassay.
4. The method according to claim 3 wherein the immunoassay is an immunohistochemical assay.
5. The method according to claim 1 wherein the differentiated lung carcinoma is selected from the group consisting of a poorly differentiated squamous cell carcinoma, a moderately differentiated squamous cell carcinoma, and a well differentiated squamous cell carcinoma.
6. The method according to claim 1 wherein the differentiated lung carcinoma is a poorly differentiated squamous cell carcinoma.
7. The method according to claim 1 wherein the undifferentiated lung carcinoma is a small cell undifferentiated carcinoma.